Trademark: 85775767
Word
PLETRICO
Status
Dead
Status Code
710
Status Date
Friday, January 20, 2023
Serial Number
85775767
Registration Number
4990990
Registration Date
Tuesday, July 5, 2016
Mark Type
4000
Filing Date
Friday, November 9, 2012
Published for Opposition
Tuesday, May 7, 2013
Cancellation Date
Friday, January 20, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jan 20, 2023
Cancelled Sec. 8 (6-Yr)
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 5, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 5, 2016
Registered-Principal Register
Jun 1, 2016
1(B) Basis Deleted; Proceed To Registration
May 31, 2016
Notice Of Allowance Cancelled
May 31, 2016
Teas Delete 1(B) Basis Received
Dec 15, 2015
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2015
Sou Extension 5 Granted
Dec 9, 2015
Sou Extension 5 Filed
Dec 9, 2015
Teas Extension Received
Jun 23, 2015
Teas Change Of Correspondence Received
Jun 5, 2015
Notice Of Approval Of Extension Request E-Mailed
Jun 4, 2015
Sou Extension 4 Granted
Jun 1, 2015
Sou Extension 4 Filed
Jun 1, 2015
Teas Extension Received
Dec 5, 2014
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2014
Sou Extension 3 Granted
Nov 20, 2014
Sou Extension 3 Filed
Nov 20, 2014
Teas Extension Received
Jun 12, 2014
Notice Of Approval Of Extension Request E-Mailed
Jun 11, 2014
Sou Extension 2 Granted
May 22, 2014
Sou Extension 2 Filed
Jun 10, 2014
Case Assigned To Intent To Use Paralegal
May 22, 2014
Teas Extension Received
Dec 18, 2013
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2013
Sou Extension 1 Granted
Dec 16, 2013
Sou Extension 1 Filed
Dec 16, 2013
Teas Extension Received
Jul 2, 2013
Noa E-Mailed - Sou Required From Applicant
May 7, 2013
Official Gazette Publication Confirmation E-Mailed
May 7, 2013
Published For Opposition
Apr 17, 2013
Notification Of Notice Of Publication E-Mailed
Mar 29, 2013
Law Office Publication Review Completed
Mar 25, 2013
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 25, 2013
Teas Change Of Owner Address Received
Mar 26, 2013
Assigned To Lie
Mar 11, 2013
Approved For Pub - Principal Register
Mar 11, 2013
Examiner's Amendment Entered
Mar 11, 2013
Notification Of Examiners Amendment E-Mailed
Mar 11, 2013
Examiners Amendment E-Mailed
Mar 11, 2013
Examiners Amendment -Written
Mar 7, 2013
Assigned To Examiner
Nov 16, 2012
New Application Office Supplied Data Entered
Nov 13, 2012
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24